Eli Lilly stock (LLY) popped by more than 5% on Wednesday after the Food and Drug Administration (FDA) approved the company's new weight-loss pill that Eli Lilly says can be taken "any time of day without food or water restrictions." The approval sets up a new phase of competition between Eli Lilly and its main competitor, Danish drugmaker Novo Nordisk (NVO), in the weight-loss drug space
Elevated cortisol promotes fat storage, increases insulin resistance, and stimulates appetite through pathways that partially bypass GLP-1 signaling
Targeting ROS in cancer: rationale and strategies
Your risk of getting low blood sugar may be higher if you use Ozempic with another medicine that can cause low blood sugar, such as sulfonylurea or insulin
Zepbound is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg for 4 weeks, then increased by 2.5 mg every 4 weeks until the recommended maintenance dose (5 mg, 10 mg, or 15 mg once weekly) is reached based on individual tolerance and therapeutic response